- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 203
Stilla gets $18m series A result
Illumina Ventures and BNP Paribas Développement have backed a series A round which will help the biotechnology company expand sales and launch a new product.
Nov 26, 2018Botkeeper brings $18m on board
Google's Gradient Ventures unit was part of a series A round that will enable the automated bookkeeping company to expand its team and bolster its marketing efforts.
Nov 26, 2018Kanova captures $16.6m series A
Legend-backed biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.
Nov 26, 2018Elens articulates $21.6m
Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.
Nov 26, 2018Corporate venturing deal net: 19-23 November 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Nov 23, 2018OMass amasses $17.9m series A
Oxford spinout OMass has pivoted from offering consulting services to developing its own drugs after closing a series A round backed by Oxford Sciences Innovation.
Nov 22, 2018Corporates take Leap in $288m series A
Leap Motor has received $288m in a round co-led by Shanghai Electric and CRRC as it prepares to launch its smart electric sports car early next year.
Nov 20, 2018Xiaoqule bands together investors to raise $108m
The community-focused e-commerce platform has raised series A funds from investors including Ping An Ventures and SIG Asia.
Nov 20, 2018Corporate venturing deal net: 12-16 November 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Nov 16, 2018Ribometrix rips $30m in Merck-led round
M Ventures led a series A round for UNC's RNA therapy spinout, while Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma also took part.
Nov 16, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


